Table Of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations

2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates

3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry

3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market

3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION
5.1. Chapter Overview
5.2. Overview of Exoskeleton
5.3. History of Exoskeleton
5.4. Classification of Exoskeleton
5.4.1. Based on Body Part Supported
5.4.2. Based on Form of Exoskeleton
5.4.3. Based on Mode of Operation
5.4.4 Based on Mobility

5.5. Applications of Exoskeleton
5.6. Features of Exoskeleton
5.7. Limitations of Exoskeleton
5.8. Future Perspectives

6. MEDICAL EXOSKELETON: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Medical Exoskeleton: Overall Market Landscape
6.2.1. Analysis by Status of Development
6.2.2. Analysis by Type of Body Part Covered
6.2.3. Analysis by Mode of Operation
6.2.4. Analysis by Type of Body Part Covered and Mode of Operation
6.2.5. Analysis by Form of Exoskeleton
6.2.6. Analysis by Mode of Operation and Form of Exoskeleton
6.2.7. Analysis by Type of Body Part Covered and Form of Exoskeleton
6.2.8. Analysis by Device Mobility

6.2.9. Analysis by Mode of Operation and Device Mobility
6.2.10. Analysis by Form of Exoskeleton and Device Mobility
6.2.11. Analysis by Type of Body Part Covered and Device Mobility
6.2.12. Analysis by User-Machine Interface
6.2.13. Analysis by Type of Body Part Covered and User-Machine Interface
6.2.14. Analysis by Mode of Operation and User-Machine Interface
6.2.15. Analysis by Availability of Advanced Features
6.2.16. Analysis by End User
6.2.17. Analysis by Patient Age Group
6.2.18. Analysis by Exoskeleton Setting for Patients
6.2.19. Analysis by Breakthrough Designation

6.3. Medical Exoskeleton: Developer: Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Analysis by Company Size and Location of Headquarters
6.3.5. Analysis by Company Ownership
6.3.6. Analysis by Location of Headquarters and Company Ownership
6.3.7. Analysis by Additional Services Offered
6.3.8. Most Active Players: Analysis by Number of Medical Exoskeleton

7. NON-MEDICAL EXOSKELETON: MARKET LANDSCAPE
7.1. Chapter Overview
7.2. Non-Medical Exoskeleton: Overall Market Landscape
7.2.1. Analysis by Status of Development
7.2.2. Analysis by Type of Body Part Covered
7.2.3. Analysis by Body Part Supported
7.2.4. Analysis by Mode of Operation
7.2.5. Analysis by Form of Exoskeleton
7.2.6. Analysis by Type of Body Part Covered and Mode of Operation
7.2.7. Analysis by Type of Body Part Covered and Form of Exoskeleton
7.2.8. Analysis by Mode of Operation and Form of Exoskeleton
7.2.9. Analysis by Application Area
7.2.10. Analysis by Mode of Operation and Application Area

7.3. Non-Medical Exoskeleton: Developer Landscape
7.3.1. Analysis by Year of Establishment
7.3.2. Analysis by Company Size
7.3.3. Analysis by Company Size and Employee Count
7.3.4. Analysis by Location of Headquarters
7.3.5. Analysis by Company Size and Location of Headquarters
7.3.6. Analysis by Company Ownership
7.3.7. Analysis by Location of Headquarters and Company Ownership
7.3.8. Most Active Players: Analysis by Number of Non-Medical Exoskeleton
7.3.9. Most Active Players: Analysis by Number of Medical and Non-Medical Exoskeleton

8. MEDICAL EXOSKELETON: PRODUCT COMPETITVENESS ANALYSIS
8.1 Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodology

8.4. Medical Exoskeleton: Product Competitiveness Analysis
8.4.1. Product Competitiveness Analysis: Upper Body Medical Exoskeleton
8.4.1.1. Product Competitiveness Analysis: Upper Body, Powered Exoskeleton
8.4.1.2. Product Competitiveness Analysis: Upper Body, Passive Exoskeleton
8.4.1.3. Product Competitiveness Analysis: Upper Body, Hybrid Exoskeleton

8.4.2. Product Competitiveness Analysis: Lower Body Exoskeleton
8.4.2.1. Product Competitiveness Analysis: Lower Body, Powered Exoskeleton
8.4.2.2. Product Competitiveness Analysis: Lower Body, Passive Exoskeleton
8.4.2.3. Product Competitiveness Analysis: Lower Body, Hybrid Exoskeleton
8.4.3. Product Competitiveness Analysis: Full Body Medical Exoskeleton

9. EXOSKELETON DEVELOPERS: DETAILED COMPANY PROFILES
9.1. Chapter Overview
9.2. CYBERDYNE
9.2.1. Company Overview
9.2.2. Financial Information
9.2.3. Product Portfolio
9.2.4 Recent Developments and Future Outlook

9.3. Ekso Bionics
9.3.1. Company Overview
9.3.2. Financial Information
9.3.3. Product Portfolio
9.3.4 Recent Developments and Future Outlook

9.4. ExoAtlet
9.4.1. Company Overview
9.4.2. Product Portfolio
9.4.3. Recent Developments and Future Outlook

9.5. Fourier Intelligence
9.5.1. Company Overview
9.5.2. Product Portfolio
9.5.3. Recent Developments and Future Outlook

9.6. Gloreha
9.6.1. Company Overview
9.6.2. Product Portfolio
9.6.3. Recent Developments and Future Outlook

9.7. Guangzhou Yikang
9.7.1. Company Overview
9.7.2. Product Portfolio
9.7.3. Recent Developments and Future Outlook

9.8. Hexar Humancare
9.8.1. Company Overview
9.8.2. Product Portfolio
9.8.3. Recent Developments and Future Outlook

9.9. Hocoma
9.9.1. Company Overview
9.9.2. Product Portfolio
9.9.3. Recent Developments and Future Outlook

9.10. Panasonic
9.10.1. Company Overview
9.10.2. Financial Information
9.10.3. Product Portfolio
9.10.4. Recent Developments and Future Outlook

9.11. Tyromotion
9.11.1. Company Overview
9.11.2. Product Portfolio
9.11.3. Recent Developments and Future Outlook

10. EXOSKELETON DEVELOPERS: TABULATED COMPANY PROFILES
10.1. Chapter Overview
10.2. Bionic Yantra
10.3. MediTouch
10.4. Milebot Robotics
10.5. Myomo
10.6. Neofect
10.7. NextStep Robotics
10.8. ReWalk Robotics
10.9. Rex Bionics
10.10. Roam Robotics
10.11. Trexo Robotics
10.12. U&O Technologies

11. MEDICAL EXOSKELETON: PARTNERSHIPS AND COLLABORATIONS
11.1. Chapter Overview
11.2. Partnership Models
11.3. Medical Exoskeleton: List of Partnerships and Collaborations
11.3.1. Analysis by Year of Partnership
11.3.2. Analysis by Type of Partnership
11.3.3. Analysis by Year and Type of Partnership
11.3.4. Analysis by Type of Partner
11.3.5. Analysis by Year of Partnership and Type of Partner
11.3.6. Analysis by Purpose of Partnership

11.3.7. Analysis by Geography
11.3.7.1. Local and International Agreements
11.3.7.2. Intracontinental and Intercontinental Agreements
11.3.7.3. Most Active Players: Distribution by Number of Partnerships

12. PATENT ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology

12.3. Exoskeleton: Patent Analysis
12.3.1. Analysis by Patent Application Year
12.3.2. Analysis by Patent Publication Year
12.3.3. Analysis by Type of Patent and Patent Publication Year
12.3.4. Analysis by Publication Time
12.3.5. Analysis by Patent Jurisdiction
12.3.6. Analysis by CPC symbols
12.3.7. Analysis by Type of Applicant
12.3.8. Leading Players: Analysis by Number of Patents
12.3.9. Leading Patent Assignees: Analysis by Number of Patents

12.4. Exoskeleton: Patent Benchmarking
12.4.1. Analysis by Patent Characteristics
12.4.2. Exoskeleton: Patent Valuation

12.5. Leading Players by Number of Citations

13. BLUE OCEAN STRATEGY
13.1. Overview of Blue Ocean Strategy
13.1.1. Red Oceans
13.1.2. Blue Oceans
13.1.3. Comparison of Red Ocean Strategy and Blue Ocean Strategy

13.1.4. Medical Exoskeleton: Blue Ocean Strategy and Shift Tools
13.1.4.1. Strategy Canvas
13.1.4.2. Pioneer-Migrator-Settler (PMS) Map
13.1.4.3. Buyer Utility Map

14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
14.1. Chapter Overview
14.2. Market Drivers
14.3. Market Restraints
14.4. Market Opportunities
14.5. Market Challenges
14.6. Conclusion

15. GLOBAL EXOSKELETON MARKET
15.1. Chapter Overview
15.2. Forecast Methodology and Key Assumptions
15.3. Global Exoskeleton Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.3.1. Scenario Analysis

15.4. Key Market Segmentations
15.5. Dynamic Dashboard

16. EXOSKELETON MARKET, BY BODY PART COVERED
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. Medical Upper Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.4. Medical Lower Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.5. Medical Full Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.6. Non-Medical Upper Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.7. Non-Medical Lower Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.8. Non-Medical Full Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.9. Overall Upper Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.10. Overall Lower Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.11. Overall Full Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.12. Data Triangulation and Validation

17. EXOSKELETON MARKET, BY MODE OF OPERATION
17.1. Chapter Overview
17.2. Forecast Methodology and Key Assumptions
17.3. Medical Powered Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.4. Medical Passive Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.5. Medical Hybrid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.6. Non-Medical Powered Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.7. Non-Medical Passive Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.8. Non-Medical Hybrid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.9. Overall Powered Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.10. Overall Passive Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.11. Overall Hybrid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.12. Data Triangulation and Validation

18. EXOSKELETON MARKET, BY THEIR FORM
18.1. Chapter Overview
18.2. Forecast Methodology and Key Assumptions
18.3. Medical Rigid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.4. Medical Soft Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.4. Non-Medical Rigid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.5. Non-Medical Soft Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.6. Overall Rigid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.7. Overall Soft Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.8. Data Triangulation and Validation

19. EXOSKELETON MARKET, BY THEIR MOBILITY
19.1. Chapter Overview
19.2. Forecast Methodology and Key Assumptions
19.3. Medical Fixed/ Supported Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.4. Medical Mobile / Overground Walking Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.5. Data Triangulation and Validation

20. EXOSKELETON MARKET, BY END USERS
20.1. Chapter Overview
20.2. Forecast Methodology and Key Assumptions
20.3. Medical Exoskeleton by Patients: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4. Medical Exoskeleton by Healthcare Providers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.5. Non-Medical Exoskeleton by Industry Workers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.6. Non-Medical Exoskeleton by Military Personnel: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.7. Non-Medical Exoskeleton by Others: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.8. Overall Exoskeleton by End Users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.9. Data Triangulation and Validation

21. EXOSKELETON MARKET, BY GEOGRAPHY
21.1. Chapter Overview
21.2. Forecast Methodology and Key Assumptions
21.3. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
21.4. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
21.5. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
21.6. Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
21.7. Data Triangulation and Validation

22. CONCLUSION

23. EXECUTIVE INSIGHTS
23.1. Chapter Overview
23.2. ABLE Human Motion
23.2.1. Company Snapshot
23.2.2. Interview Transcript

23.3. Archelis
23.3.1. Company Snapshot
23.3.2. Interview Transcript

23.4. Biomotum
23.4.1. Company Snapshot
23.4.2. Interview Transcript

23.5. Bionic Power
23.5.1. Company Snapshot
23.5.2. Interview Transcript

23.6. Bionic Yantra
23.6.1. Company Snapshot
23.6.2. Interview Transcript

24. APPENDIX 1: BLUE OCEAN STRATEGY AND SHIFT TOOLS

25. APPENDIX 2: TABULATED DATA

26. APPENDIX 3: LIST OF COMPANIES AND ORGANIZATION

List Of Figures

Figure 2.1 Research Methodology: Research Assumptions
Figure 2.2 Research Methodology: Project Methodology
Figure 2.3 Research Methodology: Forecast Methodology
Figure 2.4 Research Methodology: Robust Quality Control
Figure 2.5 Research Methodology: Key Market Segmentations
Figure 4.1 Executive Summary: Medical Exoskeleton Market Landscape
Figure 4.2 Executive Summary: Non-Medical Exoskeleton Market Landscape
Figure 4.3 Executive Summary: Partnerships and Collaborations
Figure 4.4 Executive Summary: Patent Analysis
Figure 4.5 Executive Summary: Market Forecast and Opportunity Analysis
Figure 5.1 Types of Mobility Assistive Devices
Figure 5.2 Key Historical Events related to Exoskeleton
Figure 5.3 Classification of Exoskeleton
Figure 5.4 Applications of Exoskeleton
Figure 5.5 Movements Supported by Lower Body, Upper Body and Full Body Exoskeleton
Figure 5.6 Components of a Powered / Robotic Exoskeleton
Figure 5.7 Features of Exoskeleton
Figure 5.8 Limitations of Exoskeleton
Figure 6.1 Medical Exoskeleton: Distribution by Status of Development
Figure 6.2 Medical Exoskeleton: Distribution by Type of Body Part Covered
Figure 6.3 Medical Exoskeleton: Distribution by Mode of Operation
Figure 6.4 Medical Exoskeleton: Distribution Type of Body Part Covered and Mode of Operation
Figure 6.5 Medical Exoskeleton: Distribution by Form of Exoskeleton
Figure 6.6 Medical Exoskeleton: Distribution by Mode of Operation and Form of Exoskeleton
Figure 6.7 Medical Exoskeleton: Distribution Type of Body Part Covered and Form of Exoskeleton
Figure 6.8 Medical Exoskeleton: Distribution by Device Mobility
Figure 6.9 Medical Exoskeleton: Distribution by Mode of Operation and Device Mobility
Figure 6.10 Medical Exoskeleton: Distribution by Form of Exoskeleton and Device Mobility
Figure 6.11 Medical Exoskeleton: Distribution by Type of Body Part Covered and Device Mobility
Figure 6.12 Medical Exoskeleton: Distribution by User-Machine Interface
Figure 6.13 Medical Exoskeleton: Distribution by Type of Body Part Covered and User-Machine Interface
Figure 6.14 Medical Exoskeleton: Distribution by Mode of Operation and User-Machine Interface
Figure 6.15 Medical Exoskeleton: Distribution by Availability of Advanced Features
Figure 6.16 Medical Exoskeleton: Distribution by End User
Figure 6.17 Medical Exoskeleton: Distribution by Patient Age Group
Figure 6.18 Medical Exoskeleton: Distribution by Exoskeleton Setting for Patients
Figure 6.19 Medical Exoskeleton: Distribution by Breakthrough Designation
Figure 6.20 Medical Exoskeleton Companies: Distribution by Year of Establishment
Figure 6.21 Medical Exoskeleton Companies : Distribution by Company Size
Figure 6.22 Medical Exoskeleton Companies : Distribution by Company Size and Employee Count
Figure 6.23 Medical Exoskeleton Companies : Distribution by Location of Headquarters (Region)
Figure 6.24 Medical Exoskeleton Companies : Distribution by Location of Headquarters (Country)
Figure 6.25 Medical Exoskeleton Companies : Distribution by Company Size and Location of Headquarters
Figure 6.26 Medical Exoskeleton Companies : Distribution by Company Ownership
Figure 6.27 Medical Exoskeleton Companies : Distribution by Location of Headquarters and Company Ownership
Figure 6.28 Medical Exoskeleton Companies : Distribution by Additional Services Offered
Figure 6.29 Most Active Players: Distribution by Number of Medical Exoskeleton
Figure 7.1 Non-Medical Exoskeleton: Distribution by Status of Development
Figure 7.2 Non-Medical Exoskeleton: Distribution by Type of Body Part Covered
Figure 7.3 Non-Medical Exoskeleton: Distribution by Body Part Supported
Figure 7.4 Non-Medical Exoskeleton: Distribution by Mode of Operation
Figure 7.5 Non-Medical Exoskeleton: Distribution by Form of Exoskeleton
Figure 7.6 Non-Medical Exoskeleton: Distribution by Mode of Operation and Form of Exoskeleton
Figure 7.7 Non-Medical Exoskeleton: Distribution by Type of Body Part Covered and Mode of Operation
Figure 7.8 Non-Medical Exoskeleton: Distribution by Type of Body Part Covered and Form of Exoskeleton
Figure 7.9 Non-Medical Exoskeleton: Distribution by Application Area
Figure 7.10 Non-Medical Exoskeleton: Distribution by Mode of Operation and Application Area
Figure 7.11 Non-Medical Exoskeleton Companies : Distribution by Year of Establishment
Figure 7.12 Non-Medical Exoskeleton Companies : Distribution by Company Size
Figure 7.13 Non-Medical Exoskeleton Companies : Distribution by Company Size and Employee Count
Figure 7.14 Non-Medical Exoskeleton Companies : Distribution by Location of Headquarters (Region)
Figure 7.15 Non-Medical Exoskeleton Companies : Distribution by Location of Headquarters (Country)
Figure 7.16 Non-Medical Exoskeleton Companies : Distribution by Company Size and Location of Headquarters
Figure 7.17 Non-Medical Exoskeleton Companies : Distribution by Company Ownership
Figure 7.18 Non-Medical Exoskeleton Companies : Distribution by Location of Headquarters and Company Ownership
Figure 7.19 Most Active Players: Distribution by Number of Non-Medical Exoskeleton
Figure 7.20 Most Active Players: Distribution by Number of Medical and Non-Medical Exoskeleton
Figure 8.1 Product Competitiveness Analysis: Upper Body, Powered Exoskeleton
Figure 8.2 Product Competitiveness Analysis: Upper Body, Passive Exoskeleton
Figure 8.3 Product Competitiveness Analysis: Upper Body, Hybrid Exoskeleton
Figure 8.4 Product Competitiveness Analysis: Lower Body, Powered Exoskeleton
Figure 8.5 Product Competitiveness Analysis: Lower Body, Passive Exoskeleton
Figure 8.6 Product Competitiveness Analysis: Lower Body, Hybrid Exoskeleton
Figure 8.7 Product Competitiveness Analysis: Full Body Medical Exoskeleton
Figure 9.1 CYBERDYNE: Annual Revenues, FY 2019 – FY 2023 (JPY Billion)
Figure 9.2 CYBERDYNE: Distribution of Revenues by Business Segment, FY 2021- FY 2022
Figure 9.3 Ekso Bionics: Annual Revenues, 2018 – Q1 2023 (USD Billion)
Figure 9.4 Ekso Bionics: Distribution of Revenues by Business Segment, FY 2023
Figure 9.5 Panasonic: Annual Revenues, FY 2018- FY 2023 (JPY Billion)
Figure 11.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 11.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 11.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 11.4 Partnerships and Collaborations: Distribution by Type of Partner
Figure 11.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Figure 11.6 Partnerships and Collaborations: Distribution by Purpose of Partnership
Figure 11.7 Partnerships and Collaborations: Local and International Agreements
Figure 11.8 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Figure 11.9 Most Active Players: Distribution by Number of Partnerships
Figure 12.1 Patent Analysis: Distribution by Type of Patent
Figure 12.2 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year, Pre-2016-2022
Figure 12.3 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year, 2016-2022
Figure 12.4 Patent Analysis: Distribution by Type of Patent and Patent Publication Year, 2016-2023
Figure 12.5 Patent Analysis: Distribution by Publication Time
Figure 12.6 Patent Analysis: Distribution by Patent Jurisdiction (Region)
Figure 12.7 Patent Analysis: Distribution by Patent Jurisdiction (Country)
Figure 12.8 Patent Analysis: Distribution by CPC Symbols
Figure 12.9 Patent Analysis: Distribution by Type of Applicant
Figure 12.10 Leading Industry Players: Distribution by Number of Patents
Figure 12.11 Leading Non-Industry Players: Distribution by Number of Patents
Figure 12.12 Leading Individual Assignees: Distribution by Number of Patents
Figure 12.13 Leading Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Figure 12.14 Leading Non-Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Figure 12.15 Patent Analysis: Distribution by Patent Age
Figure 12.16 Patent Analysis: Patent Valuation
Figure 13.1 Differences Between Red Ocean Strategy and Blue Ocean Strategy
Figure 13.2 Blue Ocean Strategy: Strategy Canvas
Figure 13.3 Blue Ocean Strategy: Pioneer-Migrator-Settler (PMS) Map
Figure 13.4 Blue Ocean Strategy: Buyer Utility Map
Figure 14.1 Market Drivers
Figure 14.2 Market Restrains
Figure 14.3 Market Opportunities
Figure 14.4 Market Challenges
Figure 15.1 Global Exoskeleton Market, Historical Trends (2018-2022) and Future Estimates (2023-2035) (USD Million)
Figure 15.2 Global Exoskeleton Market, Future Estimates (2023-2035), Base Scenario (USD Million)
Figure 15.3 Global Exoskeleton Market, Future Estimates (2023-2035), Conservative Scenario (USD Million)
Figure 15.4 Global Exoskeleton Market, Future Estimates (2023-2035), Optimistic Scenario (USD Million)
Figure 16.1 Medical Upper Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023- 2035)
Figure 16.2 Medical Lower Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 16.3 Medical Full Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 16.4 Non-Medical Upper Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 16.5 Non-Medical Lower Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023- 2035)
Figure 16.6 Non-Medical Full Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 16.7 Overall Upper Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 16.8 Overall Lower Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 16.9 Overall Full Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 16.10 Exoskeleton Market: Distribution by Body Part Covered, 2018, 2023 and 2035 (USD Million)
Figure 17.1 Medical Powered Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 17.2 Medical Passive Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 17.3 Medical Hybrid Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 17.4 Non-Medical Powered Exoskeleton Market: Historical Trends (2018- 2022) and Future Estimates (2023-2035)
Figure 17.5 Non-Medical Passive Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 17.6 Non-Medical Hybrid Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 17.7 Overall Powered Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 17.8 Overall Passive Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 17.9 Overall Hybrid Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 17.10 Exoskeleton Market: Distribution by Mode of Operation, 2018, 2023 and 2035 (USD Million)
Figure 18.1 Medical Rigid Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023- 2035)
Figure 18.2 Medical Soft Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 18.3 Non-Medical Rigid Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023- 2035)
Figure 18.4 Non-Medical Soft Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 18.5 Overall Rigid Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 18.6 Overall Soft Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 18.7 Exoskeleton Market: Distribution by Form, 2018, 2023 and 2035 (USD Million)
Figure 19.1 Medical Fixed / Supported Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023- 2035)
Figure 19.2 Medical Mobile / Overground Walking Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023- 2035)
Figure 19.3 Exoskeleton Market: Distribution by Device Mobility, 2018, 2023 and 2035 (USD Million)
Figure 20.1 Medical Exoskeleton Market by Patients: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.2 Medical Exoskeleton Market by Healthcare Professionals: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.3 Non-Medical Exoskeleton Market by Industry Workers: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.4 Non-Medical Exoskeleton Market by Military Personnel: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.5 Non-Medical Exoskeleton Market by Others: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.6 Overall Exoskeleton Market by End Users: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.7 Exoskeleton Market: Distribution by End Users, 2018, 2023 and 2035 (USD Million)
Figure 21.1 Exoskeleton Market in North America: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 21.2 Exoskeleton Market in Europe: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 21.3 Exoskeleton Market in Asia-Pacific: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 21.4 Exoskeleton Market in Rest of the World: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 21.5 Exoskeleton Market: Distribution by Geography, 2018, 2023 and 2035 (USD Million)
Figure 22.1 Concluding Remarks: Overall Medical Exoskeleton Market Landscape
Figure 22.2 Concluding Remarks: Overall Non-Medical Exoskeleton Market Landscape
Figure 22.3 Concluding Remarks: Partnerships and Collaborations
Figure 22.4 Concluding Remarks: Patent Analysis
Figure 22.5 Concluding Remarks: Market Forecast and Opportunity Analysis

List Of Tables

Table 5.1 Contrasting Characteristics: Medical and Non-Medical Exoskeleton
Table 5.2 Degrees of Freedom in Each Joint of Lower Exoskeleton
Table 5.3 Contrasting Characteristics: Rigid and Soft Exoskeleton
Table 6.1 Medical Exoskeleton: Information on Status of Development, Type of Body Part Covered and Mode of Operation
Table 6.2 Medical Exoskeleton: Information on Form of Exoskeleton, Device Mobility and User-Machine Interface
Table 6.3 Medical Exoskeleton: Information on Advanced Features and End Users
Table 6.4 Medical Exoskeleton: Information on Patient Age Group, Exoskeleton Setting for Patients and Breakthrough Designation
Table 6.5 Medical Exoskeleton: Information on Technology / Software, Maximum Weight of Exoskeleton, Maximum Weight Carrying Capacity and Dimensions
Table 6.6 Medical Exoskeleton: List of Developers
Table 6.7 Medical Exoskeleton: Information on Additional Services Offered
Table 7.1 Non-Medical Exoskeleton: Information on Status of Development, Type of Body Part Covered and Body Part Supported
Table 7.2 Non-Medical Exoskeleton: Information on Mode of Operation and Form of Exoskeleton
Table 7.3 Non-Medical Exoskeleton: Information on Application Area
Table 7.4 Non-Medical Exoskeleton: Information on Technology / Software, Maximum Weight of Exoskeleton, Maximum Weight Carrying Capacity and Dimensions
Table 7.5 Non-Medical Exoskeleton: List of Developers
Table 9.1 List of Medical Exoskeleton Companies Profiled
Table 9.2 Exoskeleton Companies: Information on Additional Services Offered
Table 9.3 CYBERDYNE: Company Snapshot
Table 9.4 CYBERDYNE: Medical Exoskeleton Portfolio
Table 9.5 CYBERDYNE: Non-Medical Exoskeleton Portfolio
Table 9.6 CYBERDYNE: Recent Developments and Future Outlook
Table 9.7 Ekso Bionics: Company Snapshot
Table 9.8 Ekso Bionics: Medical Exoskeleton Portfolio
Table 9.9 Ekso Bionics: Non-Medical Exoskeleton Portfolio
Table 9.10 Ekso Bionics: Recent Developments and Future Outlook
Table 9.11 ExoAtlet: Company Snapshot
Table 9.12 ExoAtlet: Medical Exoskeleton Portfolio
Table 9.13 ExoAtlet: Non-Medical Exoskeleton Portfolio
Table 9.14 ExoAtlet: Recent Developments and Future Outlook
Table 9.15 Fourier Intelligence: Company Snapshot
Table 9.16 Fourier Intelligence: Medical Exoskeleton Portfolio
Table 9.17 Fourier Intelligence: Recent Developments and Future Outlook
Table 9.18 Gloreha: Company Snapshot
Table 9.19 Gloreha: Medical Exoskeleton Portfolio
Table 9.20 Gloreha: Recent Developments and Future Outlook
Table 9.21 Guangzhou YiKang: Company Snapshot
Table 9.22 Guangzhou YiKang: Medical Exoskeleton Portfolio
Table 9.23 Guangzhou YiKang: Recent Developments and Future Outlook
Table 9.24 Hexar Humancare: Company Snapshot
Table 9.25 Hexar Humancare: Medical Exoskeleton Portfolio
Table 9.26 Hexar Humancare: Non-Medical Exoskeleton Portfolio
Table 9.27 Hexar Humancare: Recent Developments and Future Outlook
Table 9.28 Hocoma: Company Snapshot
Table 9.29 Hocoma: Medical Exoskeleton Portfolio
Table 9.30 Hocoma: Recent Developments and Future Outlook
Table 9.31 Panasonic: Company Snapshot
Table 9.32 Panasonic: Medical Exoskeleton Portfolio
Table 9.33 Panasonic: Non-Medical Exoskeleton Portfolio
Table 9.34 Panasonic: Recent Developments and Future Outlook
Table 9.35 Tyromotion:Company Snapshot
Table 9.36 Tyromotion: Medical Exoskeleton Portfolio
Table 9.37 Tyromotion: Recent Developments and Future Outlook
Table 10.1 Bionic Yantra: Company Snapshot and Product Portfolio
Table 10.2 Bionic Yantra: Medical Exoskeleton Portfolio
Table 10.3 MediTouch: Company Snapshot
Table 10.4 MediTouch: Medical Exoskeleton Portfolio
Table 10.5 Milebot Robotics: Company Snapshot
Table 10.6 Milebot Robotics: Medical Exoskeleton Portfolio
Table 10.7 Milebot Robotics: Non-Medical Exoskeleton Portfolio
Table 10.8 Myomo: Company Snapshot
Table 10.9 Myomo: Medical Exoskeleton Portfolio
Table 10.10 Neofect: Company Snapshot
Table 10.11 Neofect: Medical Exoskeleton Portfolio
Table 10.12 NextStep Robotics: Company Snapshot
Table 10.13 NextStep Robotics: Medical Exoskeleton Portfolio
Table 10.14 ReWalk Robotics: Company Snapshot
Table 10.15 ReWalk Robotics: Medical Exoskeleton Portfolio
Table 10.16 REX Bionics: Company Snapshot
Table 10.17 REX Bionics: Medical Exoskeleton Portfolio
Table 10.18 Roam Robotics: Company Snapshot
Table 10.19 Roam Robotics: Medical Exoskeleton Portfolio
Table 10.20 Roam Robotics: Non-Medical Exoskeleton Portfolio
Table 10.21 Trexo Robotics: Company Snapshot
Table 10.22 Trexo Robotics: Medical Exoskeleton Portfolio
Table 10.23 U&O Technologies: Company Snapshot
Table 10.23 U&O Technologies: Medical Exoskeleton Portfolio
Table 11.1 Medical Exoskeleton: List of Partnerships and Collaborations
Table 12.1 Patent Analysis: Top CPC Sections
Table 12.2 Patent Analysis: Top CPC Symbols
Table 12.3 Patent Analysis: List of Top CPC Codes
Table 12.4 Patent Analysis: Summary of Benchmarking Analysis
Table 12.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 12.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 12.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
Table 25.1 Medical Exoskeleton: Distribution by Status of Development
Table 25.2 Medical Exoskeleton: Distribution by Body Part Covered
Table 25.3 Medical Exoskeleton: Distribution by Mode of Operation
Table 25.4 Medical Exoskeleton: Distribution by Body Part Covered and Mode of Operation
Table 25.5 Medical Exoskeleton: Distribution by Form of Exoskeleton
Table 25.6 Medical Exoskeleton: Distribution by Mode of Operation and Form of Exoskeleton
Table 25.7 Medical Exoskeleton: Distribution by Body Part Covered and Form of Exoskeleton
Table 25.8 Medical Exoskeleton: Distribution by Device Mobility
Table 25.9 Medical Exoskeleton: Distribution by Mode of Operation and Device Mobility
Table 25.10 Medical Exoskeleton: Distribution by Form of Exoskeleton and Device Mobility
Table 25.11 Medical Exoskeleton: Distribution by Body Part Covered and Device Mobility
Table 25.12 Medical Exoskeleton: Distribution by User-Machine Interface
Table 25.13 Medical Exoskeleton: Distribution by Body Part Covered and User-Machine Interface
Table 25.14 Medical Exoskeleton: Distribution by Mode of Operation and User-Machine Interface
Table 25.15 Medical Exoskeleton: Distribution by Availability of Advanced Features
Table 25.16 Medical Exoskeleton: Distribution by End User
Table 25.17 Medical Exoskeleton: Distribution by Patient Age Group
Table 25.18 Medical Exoskeleton: Distribution by Exoskeleton Setting for Patients
Table 25.19 Medical Exoskeleton: Distribution by Breakthrough Designation
Table 25.20 Medical Exoskeleton Developers: Distribution by Year of Establishment
Table 25.21 Medical Exoskeleton Developers: Distribution by Company Size
Table 25.22 Medical Exoskeleton Developers: Distribution by Company Size and Employee Count
Table 25.23 Medical Exoskeleton Developers: Distribution by Location of Headquarters (Region)
Table 25.24 Medical Exoskeleton Developers: Distribution by Location of Headquarters (Country)
Table 25.25 Medical Exoskeleton Developers: Distribution by Company Size and Location of Headquarters
Table 25.26 Medical Exoskeleton Developers: Distribution by Company Ownership
Table 25.27 Medical Exoskeleton Developers: Distribution by Location of Headquarters and Company Ownership
Table 25.28 Medical Exoskeleton Developers: Distribution by Additional Services Offered
Table 25.29 Most Active Players: Distribution by Number of Medical Exoskeleton
Table 25.30 Non-Medical Exoskeleton: Distribution by Status of Development
Table 25.31 Non-Medical Exoskeleton: Distribution by Body Part Covered
Table 25.32 Non-Medical Exoskeleton: Distribution by Type of Support Offered
Table 25.33 Non-Medical Exoskeleton: Distribution by Mode of Operation
Table 25.34 Non-Medical Exoskeleton: Distribution by Form of Exoskeleton
Table 25.35 Non-Medical Exoskeleton: Distribution by Mode of Operation and Form of Exoskeleton
Table 25.36 Non-Medical Exoskeleton: Distribution by Body Part Covered and Mode of Operation
Table 25.37 Non-Medical Exoskeleton: Distribution by Body Part Covered and Form of Exoskeleton
Table 25.38 Non-Medical Exoskeleton: Distribution by Application Area
Table 25.39 Non-Medical Exoskeleton: Distribution by Mode of Operation and Application Area
Table 25.40 Non-Medical Exoskeleton Developers: Distribution by Year of Establishment
Table 25.41 Non-Medical Exoskeleton Developers: Distribution by Company Size
Table 25.42 Non-Medical Exoskeleton Developers: Distribution by Company Size and Employee Count
Table 25.43 Non-Medical Exoskeleton Developers: Distribution by Location of Headquarters (Region)
Table 25.44 Non-Medical Exoskeleton Developers: Distribution by Location of Headquarters (Country)
Table 25.45 Non-Medical Exoskeleton Developers: Distribution by Company Size and Location of Headquarters
Table 25.46 Non-Medical Exoskeleton Developers: Distribution by Company Ownership
Table 25.47 Non-Medical Exoskeleton Developers: Distribution by Location of Headquarters and Company Ownership
Table 25.48 Most Active Players: Distribution by Number of Non-Medical Exoskeleton
Table 25.49 Most Active Players: Distribution by Number of Medical and Non-Medical Exoskeleton
Table 25.50 CYBERDYNE: Annual Revenues, FY2019 – FY2023 (JPY Billion)
Table 25.51 CYBERDYNE: Distribution of Revenues by Business Segment, FY 2021- FY 2022
Table 25.52 Ekso Bionics: Annual Revenues, 2018 – Q1 2023 (USD Billion)
Table 25.53 Ekso Bionics: Distribution of Revenues by Business Segment, FY 2023
Table 25.54 Panasonic: Annual Revenues, FY 2018- FY 2023 (JPY Billion)
Table 25.55 Partnerships and Collaborations: Distribution by Year of Partnership
Table 25.57 Partnerships and Collaborations: Distribution by Type of Partnership
Table 25.58 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 25.59 Partnerships and Collaborations: Distribution by Type of Partner
Table 25.60 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Table 25.61 Partnerships and Collaborations: Distribution by Purpose of Partnership
Table 25.62 Partnerships and Collaborations: Local and International Agreements
Table 25.63 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Table 25.64 Most Active Players: Distribution by Number of Partnerships
Table 25.65 Patent Analysis: Distribution by Type of Patent
Table 25.66 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year, Pre-2016-2022
Table 25.67 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year, 2016-2022
Table 25.68 Patent Analysis: Distribution by Type of Patent and Patent Publication Year, 2016-2023
Table 25.69 Patent Analysis: Distribution by Publication Time
Table 25.70 Patent Analysis: Distribution by Patent Jurisdiction (Region)
Table 25.71 Patent Analysis: Distribution by Patent Jurisdiction (Country)
Table 25.72 Patent Analysis: Distribution by CPC Symbols
Table 25.73 Patent Analysis: Distribution by Type of Applicant
Table 25.74 Leading Industry Players: Distribution by Number of Patents
Table 25.75 Leading Non-Industry Players: Distribution by Number of Patents
Table 25.76 Leading Individual Assignees: Distribution by Number of Patents
Table 25.77 Leading Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Table 25.78 Leading Non-Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Table 25.79 Patent Analysis: Distribution by Patent Age
Table 25.80 Patent Analysis: Patent Valuation
Table 25.81 Global Exoskeleton Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 25.82 Global Exoskeleton Market, Forecasted Estimates (2023-2035), Base Scenario (USD Million
Table 25.83 Global Exoskeleton Market, Forecasted Estimates (2023-2035) Conservative Scenario (USD Million)
Table 25.82 Global Exoskeleton Market, Forecasted Estimates (2023-2035), Optimistic Scenario (USD Million)
Table 25.83 Non-Medical Upper Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023- 2035)
Table 25.84 Non-Medical Lower Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.5 Non-Medical Full Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.86 Medical Upper Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.87 Medical Lower Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.88 Medical Full Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.89 Overall Upper Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.90 Overall Lower Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.91 Overall Full Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.92 Exoskeleton Market: Distribution by Body Part Covered, 2018, 2023 and 2035 (USD Million)
Table 25.93 Non-Medical Powered Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023- 2035)
Table 25.94 Non-Medical Passive Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.95 Non-Medical Hybrid Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.96 Medical Powered Exoskeleton Market: Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
Table 25.97 Medical Passive Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.98 Medical Hybrid Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.99 Overall Powered Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023- 2035)
Table 25.100 Overall Passive Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.101 Overall Hybrid Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.102 Exoskeleton Market: Distribution by Mode of Operation, 2018, 2023 and 2035 (USD Million)
Table 25.103 Non-Medical Rigid Exoskeleton Market: Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
Table 25.104 Non-Medical Soft Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.105 Medical Rigid Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.106 Medical Soft Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.107 Overall Rigid Exoskeleton Market: Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
Table 25.108 Overall Soft Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.109 Exoskeleton Market: Distribution by Form 2018, 2023 and 2035 (USD Million)
Table 25.110 Medical Fixed / Supported Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.111 Medical Mobile / Overground Walking Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.112 Exoskeleton Market: Distribution by Device Mobility, 2018, 2023 and 2035 (USD Million)
Table 25.113 Medical Exoskeleton Market by Patients: Historical Trends (2018-2022) and Forecasted Estimates (2023- 2035)
Table 25.114 Medical Exoskeleton Market by Healthcare Professionals: Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
Table 25.115 Non-Medical Exoskeleton Market by Industry Workers: Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
Table 25.116 Non-Medical Exoskeleton Market by Military Personnel: Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
Table 25.117 Non-Medical Exoskeleton Market by Others: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.118 Overall Exoskeleton Market by End Users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.119 Exoskeleton Market: Distribution by End Users,2018, 2023 and 2035 (USD Million)
Table 25.120 Exoskeleton Market in North America: Historical Trends (2018-2022) Forecasted Estimates (2023- 2035)
Table 25.121 Exoskeleton Market in Europe: Historical Trends (2018-2022) Forecasted Estimates (2023- 2035)
Table 25.122 Exoskeleton Market in Asia-Pacific: Historical Trends (2018-2022) Forecasted Estimates (2023- 2035)
Table 25.123 Exoskeleton Market in Rest of the World: Historical Trends (2018-2022) Forecasted Estimates (2023- 2035)
Table 25.124 Exoskeleton Market: Distribution by Geography, 2018, 2023 and 2035 (USD Million)

List Of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report.

1. 20 Knots Plus (20KTS+)
2. Abdul Latif Jameel
3. Abilitech Medical
4. ABLE Human Motion
5. AGADE
6. Againer
7. Airbus
8. Akina
9. Alias Robotics
10. Alpha Quantix
11. Amazon
12. Anatomical Concepts
13. Angel Robotics
14. Anhui Ryzur Medical Equipment Manufacturing
15. Archelis
16. Arrow Electronics 
17. Assistive Innovations
18. Astride Bionix
19. Asuka
20. Aurora 
21. Autonomyo
22. Auxivo
23. Auxsys
24. awb
25. Axosuits
26. BAMA Technology
27. B-Bridge
28. Big Bang Boom Solutions (BBBS)
29. Biolift
30. Biomotum
31. Bionic Power
32. Bionic Yantra
33. BIONIK Laboratories
34. Bioservo Technologies
35. BKK Mobil Oil
36. BoBo
37. Bond University
38. Boston University
39. Boston University Neuromotor Recovery Laboratory
40. Brillinger
41. Brooks Rehabilitation
42. B-Temia
43. C2
44. Cadence Biomedical
45. Carl Stahl
46. C-Exoskeleton 
47. Carl Stahl Sava Industries
48. Comau
49. Competence Centre for Rehabilitation Engineering and Science (RESC) 
50. Coopselios
51. Cosmos Bionics
52. Crimson Dynamics 
53. Curexo
54. Cyber Human Systems
55. CYBERDYNE
56. Daehan Rehabilitation Hospital
57. Daewoo E&C
58. Daiya 
59. Dephy
60. Deutsche Angestellten-Krankenkasse – Gesundheit
61. Ectron
62. Eiffage
63. Ekso Bionics
64. Ekzar34
65. Element Exo
66. Emovo Care
67. Endoenergy Systems
68. Enhanced Robotics 
69. Ergo Diffusion
70. ErgoSanté
71. Everest IMS Technologies
72. Exaurus
73. EXHAUSS
74. ExoAtlet
75. EXOesqueleto REHAB
76. ExoIQ
77. Exomed
78. Exomys – Augmented Humanity
79. Exorise
80. ExoSkeleton Innovations
81. Exy
82. European Center of Neurosciences
83. Festool
84. Fischer Connectors
85. Flinders University
86. Florida Rehabilitation Center (a subsidiary of BIONIK Laboratories)
87. FM Logistic
88. Fourier Intelligence
89. FREE Bionics
90. FREI
91. GenElek Technologies
92. General Electric
93. General Incorporated Association
94. German Bionic
95. G-Hoo
96. Gloreha
97. Gogoa
98. Gorbel
99. Guangzhou Hyetone Industrial Technology
100. Guangzhou Yikang Medical Equipment 
101. Gulf Medical University
102. H Robotics
103. Hampshire Country Council
104. HaptX
105. Harmonic Bionics
106. Harmonie Medical Service
107. Harvard University
108. HASOMED
109. Health2Work
110. Health Canada
111. Healthlink Holdings
112. Hellstern medical
113. HeroWear
114. Hexar Humancare
115. Hidrex
116. Hjelpemiddelpartner
117. Hilti
118. HKK Bionics
119. Hobbs Rehabilitation 
120. Hocoma
121. Honda
122. HoustonBionics
123. hTrius
124. Human in Motion Robotics
125. Human Mechanical Technologies (HMT)
126. HumaniX
127. Humotech
128. Hunic
129. Hypershell
130. Hyundai Motor
131. Innophys
132. Institute of Computing Technology Chinese Academy of Sciences
133. InteSpring
134. ITURRI
135. IUVO
136. JAECO Orthopedic
137. Japan Agency for Medical Research and Development
138. Japet 
139. John Hopkins Aramco Healthcare
140. JTEKT
141. J-Workout
142. Keidanren
143. Keystone Education 
144. Kindred Healthcare
145. Kubota
146. Laevo
147. Levier
148. Levitate Technologies
149. LeyLine (a subsidiary of CYBERDYNE)
150. LIFESCAPES
151. Life Sciences Research Office
152. LG Electronics
153. Lifepoint Health
154. Lockheed Martin
155. Macquarie University
156. Marsi Bionics
157. Marubeni Ina Mirai Denki
158. Mawashi Science & Technology
159. maxon 
160. MebotX
161. Mebster
162. Mech Lab
163. Meditas Oy
164. MediTouch
165. Metta Medtech
166. MIHARU
167. Milebot Robotics
168. Ministry of Health of the Kingdom of Saudi Arabia
169. MIRAISENS
170. Mitsubishi Heavy Industries (MHI)
171. Motek Medical
172. Motive Labs
173. Motorika
174. MotorSkins
175. Moveo
176. MPC Healthcare
177. MyndTec
178. Myomo
179. MyoSwiss
180. National Robotarium
181. National University of Singapore 
182. Neofect
183. NeuroMuscular Orthotics
184. Neurolutions
185. Newndra 
186. NextStep Robotics
187. noonee
188. NovaHealth TCM Clinic
189. Nuada
190. Ocalis
191. OIM Sweden
192. Origin Polska
193. Oslo Municipality
194. Össur
195. Otherlab
196. Ottobock
197. P&S Mecanics
198. Pace Rehabilitation
199. Panasonic
200. Parker Hannifin 
201. PedaSys
202. PhaseX AB
203. PolySpine
204. Pro-Med
205. Protesto
206. Rake Technologies
207. RB3D
208. Reactive Robotics
209. Reboocon Bionics
210. Reev
211. Reha Technology
212. Rehab
213. RehabMart
214. Rehab-Robotics
215. Rehasys
216. RETOucH 
217. ReWalk Robotics
218. Rex Bionics
219. Rhino Assembly
220. RISE
221. Roam Robotics
222. RoboCT
223. Robo-Mate
224. RoboSuits
225. Roceso Technologies
226. Roki Robotics
227. Royal Rehab
228. RTX 
229. RWTH Aachen University
230. Saebo
231. Samsung
232. Sarcos Technology and Robotics
233. SensoRehab
234. Seoul National University
235. Shanghai Siyi Intelligence Technology
236. Shirley Ryan AbilityLab (SRAL)
237. Skelex
238. Ski~Mojo
239. SolidWorks
240. Sonceboz
241. Spectrum Ergonomics 
242. SpringActive
243. STEPS Rehabilitation
244. StrongArm 
245. SuitX (a subsidiary of Ottobock)
246. Summit Medical and Scientific
247. Sunway Medical Centre
248. Svaya Robotics
249. Technaid
250. Techniker Krankenkasse
251. Tecno Italia
252. Tendo
253. The Fraternal Order of Eagles
254. Thor Assistive Technologies
255. Tonus 
256. Toyota Motor
257. Trexo Robotics
258. TsNIITochMash 
259. Twiice
260. Tyromotion
261. U&O Technologies
262. Uchida
263. ULS Robotics
264. University of California
265. University of Michigan
266. University of New South Wales
267. University of Queensland
268. United States Military Academy West Point
269. University of Texas
270. University of Utah
271. United States Special Operations Command (USSOCOM)
272. U.S. Army Medical Research and Materiel Command (USAMRMC)
273. U.S. Army Combat Capabilities Development Command Army Research Laboratory (DEVCOM ARL)
274. USCI 
275. U.S. Department of Veterans Affairs
276. US Physiatry (USP)
277. Verve Motion
278. Vilje Bionics
279. Wandercraft
280. Weiss Medical
281. Wearable Robotics
282. Wistron 
283. Works Applications
284. WQ Park 
285. Xeno Dynamics
286. Y's Rehabilitation Center